Introduction

Rhabdomyosarcoma(RMS) is the most common soft tissue sarcoma and primary orbital malignancy in childhood. The annual incidence of RMS is approximately 4.5 cases per million in children. The head and neck region is the most frequent site, accounting for 35-40% of all cases1,2. In children, orbital RMS accounts for 25-35% of the head and neck soft tissue malignant tumors3,4. Since RMS is a lifethreatening malignant tumor, proper and early diagnosis  is of great importance in saving the lives of patients. However, RMS does not have specific clinical manifestations, which make it difficult to diagnose clinically in preoperative evaluation.

The advancements in neuroimaging techniques have led to magnetic resonance imaging (MRI) becoming a powerful tool in the diagnosis of orbital RMS. However, literature searches on RMS reveal that most reports focus on the patient’s clinical spectrum or life prognosis after various treatments; only a few case reports have described the MRI findings of orbital RMS5-8. In these case reports, which have very small sample sizes, the main MRI finding for orbital RMS was a soft tissue mass with moderate to marked contrast enhancement. Little description was provided for the diagnostic features, nor were new MRI techniques applied, such as diffusion weighted imaging(DWI) and susceptibility weighted imaging (SWI).Thus, detailed MRI features of RMS are scarce.

The goal of this study was to describe and define the clinical, imaging, and pathological changes of RMS, with particular emphasis on the various MRI features including structure, DWI, and SWI.

Materials and methods

This study was approved by the institutional review board, and the clinical records and MRI data of 39 consecutive patients with histologically proven RMS over a 5-year period (from October 2007 to November 2012) were retrospectively reviewed.

All patients underwent orbital conventional MRI before surgery. MRI was performed on a 3.0 T scanner (TRIO TIM, Siemens Medical Systems) with a SENSE 8-channel head coil. In total, 17 children required sedation for MRI. Chloral hydrate was used under a standard sedation protocol with direct supervision by a research nurse until each child had returned to baseline state. conventional clinical pulse sequences were used, including axial, sagittal, and coronal T1-weighted fast low-angle shot sequences [slice thickness=3 mm, intersection gap=0.3 mm, slice number=19, time repetition (TR)/time echo (TE)=1900/2.5 ms, field of view (FOV)=190×190 mm, band width (BW)=269 Hz, flip angle (FA)= 70。], and axial, sagittal, and coronal T2-weighted turbo spin echo sequences  (slice thickness =3 mm, intersection gap=0.3 mm, slice number=19, TR/TE=3300/108 ms, FOV=190×190 mm, BW=363Hz, flip angle=140。).

DWI measurement was performed in the axial plane using a SE-EpI sequence and b-values of 0, 500, and 1000 s/mm2 (slice thickness=3 mm, intersection gap=0.3 mm, slice number=19, TR/TE=3200/99 ms, FOV=190×190mm, BW=1240 Hz) in 15 patients.

SWI measurement was performed in the axial plane using a three-dimensional gradient recalled echo sequence (slice thickness =1.2 mm, slice num ber=128, TR/TE=28ms/20ms, FOV=220×220 mm, flip angle=15。, matrix=512×512) in 2 patients.

Postcontrast axial, sagittal, and coronal T1-weighted imaging (T1WI) with fat saturation was acquired with the same parameters as the precontrast T1WI in all patients. Gadopentetate Dimeglumine (Bayer Schering pharma AG, Berlin, Germany) was intravenously injected at a dose of 0.1 mmol/kg of body weight.

MR images were reviewed on a Siemens parallel processing  workstation  by  3  radiologists  (HW, XTM, and CNW with 22, 10, and 5 years of working experience, respectively), and  consensus  was reached by discussion.

Results

The patients enrolled in the study included 22 females (56.4%) and 17 males (43.6%). The median age was 7 years  (age ranged from 2 to 38 years). The disease course ranged from 10 to 90 days (mean 30.80±18.78 days). All 39 patients underwent surgical removal of the lesions, and 6 of them had relapses after operation.  All the recurrent patients underwent secondary surgery or radiation therapy. The common  symptoms  were  as  follows: progressive proptosis (33 patients, 84.6%), globe displacement (25 patients, 64.1%), conjunctival and eyelid swelling (19 patients, 48.7%), blepharoptosis (14 patients, 35.9% ), palpable mass (10 patients, 25.6% ), and pain (4 patients, 10.3%).

Orbital MRI was available in 39 patients and revealed a soft tissue mass in the orbital region in all cases. All the lesions were unilateral. The involved side was the right side in 20 cases (51.3%) and the left side in 19 cases (48.7%). The lesions showed a well-defined margin in 33 cases (84.6%) and ill-defined in 6 cases (15.4%). Of the 39 patients, the primary tumor site was limited to the orbital proper in 31 cases (79.4% ); 28  showed extraocular muscle invasion (71.8%). Sinus invasion by the orbital tumor was found in 5 cases (12.8%; maxillary sinus in 3 cases, ethmoidal sinus in 1 case; involvement in both ethmoidal and nasal sinus in 1 case).  Intracranial invasion was detected in the remaining 3 cases (7.7%) (Figure.1). In all, 34 cases showed homogeneous isointense or slightly hypointense signals on T1WI and hyperintense signal on T2WI compared with the signals of extraocular muscles(87.2%). Five cases had heterogeneous signals with focal areas of increased signal on T1WI and decreased signal on T2WI, including l case with hypointense signal on SWI, indicating  chronic  or  subacute  hemorrhage (12.8% ) (Figure 2). DWI showed a hyperintense signal in 15 cases and the mean apparent diffusion coefficient (ADC) value of the solid part of the 15 lesions was  (0.925±0.09)×l0-3 mm2/s (Figure 3). All cases showed moderate to marked enhancement after contrast administration (100%).

Two cases were misdiagnosed as capillary hemangioma and 1 case was misdiagnosed as lymphangioma before operation, and triamcinolone acetonide injection was given to these patients. After treatment, however, the lesions increased significantly. RMS was diagnosed after tumor resection.

Typical histopathological features were confirmed in 32 cases(82.1%). Seven cases only showed histopathological features of malignant small cell tumors, and were ultimately confirmed as RMS by immunohistochemistry study (17.9%).

Figure 1  A 2-year-old boy with embryonal rhabdomyosarcoma with ethmoidal sinus and intracranial invasion.


Figure 1A-C: Axial T1WI, T2WI and sagittal T2WI demonstrated a superonasal lesion in the right orbit with ethmoidal sinus and intracranial invasion. Figure 1D-F: The lesion and the invaded meninges showed marked heterogeneous enhancement on postcontrast axial, coronal, and sagittal T1WI with fat saturation.

Figure 2  A l0-year-old boy with heterogeneous rhabdomyosarcoma with nasal invasion.

Figure 2A-B:  Axial T1WI and T2WI demonstrated a lesion with heterogeneous signals with focal areas of increased signal on T1WI and decreased signal on T2WI (arrow). The lesion also showed nasal invasion. Figure 2C: The lesion showed focal areas with hypointense signal on SWI (arrow).Figure 2D-F: The lesion showed heterogeneous enhancement on postcontrast axial, coronal, and sagittal T1WI with fat saturation.

Figure 3  A 2-year-old boy with embryonal rhabdomyosarcoma.

Figure 3A: Axial T1WI demonstrated an oval extraconal lesion in the right orbit with an isointense signal relative to the muscle. Figure 3B: The lesion showed a heterogeneously hyperintense signal on T2WI. Figure 1C: The lesion showed a hyperintense signal on DWI (b=1000). Figure 3D-F: The lesion showed a marked heterogeneous enhancement on postcontrast axial, coronal, and sagittal T1WI with fat saturation.

Discussion

RMS is the most common primary orbital malignant tumor in children, occurring primarily in patients from age 2 to 10. However, the tumor could occur at any age from birth to adulthood, even up to 78 years of age2,4. The oldest patient in this study was 38 years of age. Clinically, orbital RMS usually presents with a spectrum of non-specific symptoms, including painlessly and rapidly progressing unilateral proptosis, eyelid edema, conjunctival congestion, and blepharoptosis, etc. It is difficult to arrive at a correct diagnosis purely based on clinical manifestations.

MRI was crucial in the preoperative evaluation of orbital RMS, especially in determining the tumor location and margin, and in evaluating the residual or recurrent lesions. Orbital RMS presents  some MRI characteristics. On T1WI, the tumor may appear as an isointense to hypointense  signal compared with the extraocular muscles. On T2WI, RMS tumor can present as a hyperintense, isointense, and even hypointense signal with respect to both extraocular muscles and orbital fat. On postcontrast T1WI, RMS shows moderate to marked enhancement. In  some cases, especially in children under two years of age, a highly vascular internal architecture with marked enhancement, mimicking a capillary hemangioma, may be seen, and it can be easily misdiagnosed. When RMS presents bone erosion and intracranial extension, special attention should be paid because it necessitates different operation access9, 10. In our study, 8 patients had sinus, intracranial, and bone invasion, and MRI clearly showed the scope of extension.

DWI is sensitive to the histological and physiological status of tumors and can be helpful in the differential diagnosis. Some authors suggest that ADC values may provide quantitative information that was useful for differentiating between the benign (mean ADC value=1.57±0.33×10-3mm2/s) and malignant lesions (mean ADC value=0.84±0.34×10-3 mm2/s) in the orbit; the threshold value for differentiating malignant orbital tumors from benign lesions was 1.15× l0-3 mm2/s11,12.  The 15 lesions in the present study showed relatively low ADC values (mean ADC value=0.925±0.09×10-3 mm2/s),  which was consistent with the malignant lesions.

SWI provides a new means to enhance contrast. It is three to six times more sensitive than conventional T2*-weighted gradient-echo sequences in determining the size, number, volume, and distribution of intratumoral hemorrhages, and it is also more specif- ic in differentiating the hemorrhage from other similar lesions and artifacts13,14. In this study, 2 cases underwent SWI measurement. one case had heterogeneous signals with focal areas of increased signal on T1WI and decreased signal on T2WI, and showed central hypointense signal on SWI, which was defined as intratumoral hemorrhage.

RMS should be differentiated from other lesions in the orbit, including orbital cellulitis, idiopathic inflammatory orbital pseudotumor, capillary hemangioma, lymphangioma, Langerhans’ cell histiocytosis, dermoid cyst, etc. Most of those conditions can be differentiated by clinical history and MR examination. Orbital cellulitis is more common than RMS, and usually shows sinus and orbital inflammation, and subperiosteal abscess near the medial wall of the orbit. A DWI sequence with parallel acquisition should improve the diagnostic confidence15. Idiopathic inflammatory orbital pseudotumor generally shows more inflammatory signs, including enlargement of the muscle, a finding that would be highly unlikely in RMS. A trial of corticosteroids is helpful in differentiating between idiopathic orbital inflammation and RMS16. Orbital capillary hemangioma generally appears in infants during the first few months of life, and it generally presents with a slow growing feature17. orbital  lymphangioma  frequently reveals blood levels in the larger cystic spaces that comprise the mass. These hemorrhagic cysts would be unlikely in RMS18. Langerhans’ cell histiocytosis  generally arises in bone and produces atypical bony destruction, which would be rare in orbital RMS19. Dermoid cyst usually locates near the superotemporal orbital rim. MRI characteristically shows a cystic component and no enhancement.

Based on its histopathological characteristics, RMS can be categorized into different subtypes. For most RMS cases, the subtype of tumor can be determined by pathological examination after surgery. For a small number of cases, diagnosis of the subtype can be difficult because of the overlap of pathological characteristics among different subtypes.  In this study, 32 cases were diagnosed as orbital RMS by histopathological characteristics. For the remaining 7 cases, the tumors were initially diagnosed as small cell tumors by histopathological characteristics, and were ultimately confirmed as RMS by immunohistochemistry.

In conclusion, RMS is the most common primary orbital malignancy in children and can be evaluated and diagnosed by MRI. Several important MRI features should be considered to better understand the disease, which include rapidly developing unilateral proptosis in childhood, well-demarcated homogeneous soft tissue masses with extraocular muscle invasion, isointense or slightly hypointense signals on T1WI, hyperintense signals on T2WI, relatively low ADC values, and moderate to marked enhancement.